Related Experiment Videos

Obesity and Type 2 diabetes mellitus

¹University Hospital Aintree, Liverpool, UK.

Diabetic Medicine : a Journal of the British Diabetic Association

|June 29, 2000

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Obesity in the global haemophilia population: prevalence, implications and expert opinions for weight management.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2018

Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up.

Primary care diabetes·2017

Dapagliflozin in type 2 diabetes: effectiveness across the spectrum of disease and over time.

International journal of clinical practice·2014

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin.

Diabetes, obesity & metabolism·2013

Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin.

Diabetes, obesity & metabolism·2012

The adipokine zinc-alpha2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity.

Clinical endocrinology·2009

See all related articles